In The News
Judge approves $180M settlement in stolen wages class action
Real estate ‘mogul’ Sasha Hopkins slapped with $1.25M fine
Google faces potential class action over AdTech dominance
High Court cases could push Blue Sky class action trial to 2026
Dominique Grubisa’s companies illegally scraped court websites: OAIC
Court approves landmark $75M detention centre class action settlement
Burger ad beef between McDonald’s, Hungry Jack’s done
Bubble tea chain Chatime fined for underpaying staff
Class action probe accuses union of forcing staff to join Labor Party
Travelex wins opposition to blockchain tech company’s trade marks
Please login to bookmarkClose

Generic drug maker Sandoz AG has filed proceedings seeking the revocation of two patents registered in Australia by German pharmaceutical giant Bayer covering its top-selling blood clot drug Xarelto.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au